2016
DOI: 10.1016/j.nbd.2016.07.022
|View full text |Cite
|
Sign up to set email alerts
|

Neuropeptide Y (NPY) as a therapeutic target for neurodegenerative diseases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
91
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 103 publications
(96 citation statements)
references
References 313 publications
3
91
0
Order By: Relevance
“…Such deregulation affects body weight, food intake, sleep patterns (Nixon et al, ), and could contribute to progression of age‐related pathologies, such as Parkinson's disease (Wienecke et al, ) and Alzheimer's disease (Slats et al, ). Therefore, orexin system represents a promising target for pharmacological therapies (Duarte‐Neves, de Almeida, & Cavadas, ; Tsuneki et al, ). Previous studies suggest that NPY system is also linked to the aging process; however, its role has not been completely clarified.…”
Section: Introductionmentioning
confidence: 99%
“…Such deregulation affects body weight, food intake, sleep patterns (Nixon et al, ), and could contribute to progression of age‐related pathologies, such as Parkinson's disease (Wienecke et al, ) and Alzheimer's disease (Slats et al, ). Therefore, orexin system represents a promising target for pharmacological therapies (Duarte‐Neves, de Almeida, & Cavadas, ; Tsuneki et al, ). Previous studies suggest that NPY system is also linked to the aging process; however, its role has not been completely clarified.…”
Section: Introductionmentioning
confidence: 99%
“…NPY is one of the most abundant neuropeptides within the brain and exerts (through its receptors, named Y1 to 6) an important role in many physiological functions such as food intake, energy homeostasis, circadian rhythm, cognition, stress response, neurogenesis, and neuroprotection [6, 5558]. …”
Section: Neuropeptidergic Systems In Autophagymentioning
confidence: 99%
“…Finally, NPY exerted a neuroprotective effect in the striatum and cerebellum of two mouse models of the spinocerebellar ataxia type 3 [61], a disease characterised by autophagic defects. Authors thus suggested that this action may be related to an activation of protein clearance mechanisms such as autophagy, even though additional data are mandatory to support this hypothesis [58, 61]. Overall, the potential of NPY to delay neurodegeneration through autophagy stimulation as a strategy to clear abnormal, misfolded proteins that cause neurodegenerative diseases deserves to be investigated in detail.…”
Section: Neuropeptidergic Systems In Autophagymentioning
confidence: 99%
“…AD is the most frequent type of dementia that occurs in middle to late life [29]. It is characterized by widespread neurodegeneration throughout the basal forebrain, cortex, and limbic system as a result of neuronal and synaptic loss [30].…”
Section: Adult Neurogenesis In Alzheimer Diseasementioning
confidence: 99%
“…PD is the second most common neurodegenerative disorder after AD [29]. PD is well known as a progressive, chronic neurodegenerative disease causing motor disorders such as hypokinesia, rigidity, tremor, and postural instability as well as exhibiting nonmotor symptoms including depression, anxiety, cognitive and olfactory deficits, and autonomic dysfunction [30].…”
Section: Adult Neurogenesis In Parkinson Diseasementioning
confidence: 99%